Biased on or bought by the cigarette industry?

Passionate fighters for nicotine products on the free market: Some may want to help the small group of smokers, who think that they cannot stop combustibles without e-cigarettes, some may be biased and disregarding the overwhelming results of independent research and others are bought by the tobacco and nicotine industry. Some of the following names appear time and again in campaigns which seem to pretend to care about health, but in fact promote business with nicotine products and undermine the "end game" efforts. Some persons listed below founded special front groups for the tobacco industry like KAC, CAPHRA, CHRE, GSTHR, IEA, ADIT, BCW, SCOHRE, think tanks, etc. and some are paid by FSFW ("Foundation for a Smokefree World" or "Global Action to End Smoking" - GAES, headed by the lawyer C. Douglas, who was sent before as a spy to FCA, Am. Lung Association, Am. Cancer Society, Michigan Hlth Dpmt) like BOTEC. Many front groups for vaping have their base in U.K. (e.g. JCIC) or U.S.A. (e.g. TPA) and are right wing groups (e.g. ATLAS). Blogs (2018-24) list collaborators of Juul.

David B. Abrams, PhD; AdamSmithInstitute, London; Marion Adler, PhD; Jasjit S Ahluwalia, MD, MPH, MS; Sanjay Agrawal, MD, MBChB, Leicester; Deborah Arnott, ASH-London; Philippe Arvers, MD, PhD; Paul Aveyard, PhD, Oxford; Frank Baeyens, PhD; Shamsul Bahri Mohd Tamrin; Scott D. Ballin, JD; Clive Bates, MA, MSc; Linda Bauld, PhD (social policy); Robert Beaglehole, MD, DSc, FRSNZ; Carolyn Beaumont, MD; Neal Benowitz, MD; Beem FM; Mihi Blair (Ngāti Whātua); Ilze Bogdanovica, Nottingham; Ruth Bonita, PhD; Alan Boobis, PhD; Anne Borgne, MD; Ron Borland, PhD; Botts Tanaia & David; Thomas H. Brandon, PhD; John Britton, MD, Nottingham; Dr Jamie Brown, PhD Psychol, London; Sarah Cooner; Jean-Pierre Couteron; Sharon Cox, PhD, London; Kenneth Michael Cummings, PhD; Lynne Dawkins, PhD, London; Jean-Michel Delile, MD; Martin Dockrell; Clifford Douglas, JD; Katherine East, London; Allan C. Erickson; Jean-François Etter, PhD; Matthew Evison, MD; Konstantinos Farsalinos, MD, MPH; Ian Fearon; Antoine Flahault, MD, PhD ; Jonathan Foulds, PhD; Coral Gartner, Univ.Queensland; Thomas J. Glynn, PhD; Ernest Groman, MD; Marc Gunther, Peter Hajek, PhD (Psych), Queen Mary Univ. London; Wayne Hall, PhD; Jamie Hartmann-Boyce, PhD, Oxford; Thomas Hering, MD; Natasha A. Herrera; Delon Human, MD; Sarah Jackson, London; Martin J Jarvis, DSc OBE, London; Martin Juneau, MPs, MD, FRCPC; Dr.Aparajeet Kar, MD; Donald Kenkel, PhD (economics); Leon Kosmider, PhD, PharmD; Lynn T. Kozlowski, PhD; Eva Kralikova, MD; Hiroya Kumamaru, MD, PhD; David Levy, PhD (Economics); George Laking, MD; Christopher E. Lalonde, PhD; Murray Laugesen QSO; Peter N. Lee; Jacques Le Houezec, PhD; Nicola Lindson, Oxford; Liu Zhao, PhD; William Lowenstein, MD; Karl E Lund, PhD; Olivia Maynard, PhD; Andy McEwen, PhD; Ann McNeill PhD, London; Klim McPherson, PhD; Hayden McRobbie, PhD, Bernhard-Michael Mayer, PhD (Chemistry); Colin Mendelsohn, MD; Robin Mermelstein, PhD; Faares Mili, MD; Thomas J. Miller; Ute Mons, PhD (Economics, Sociology); Marcus Munafò, PhD (psychology), Bristol; John Newton, PhD, Manchester; Raymond Niaura, PhD; Joel Nitzkin, MD; Caitlin Notley, PhD, Norwich; David Nutt, DM, FRCP, FRCPsych, FMedSci, DLaws; John Oyston, MD.; Francesca Pesola, PhD, London; Riccardo Polosa. MD; Pope Ian, MD; Wolfgang Popp, MD, Konstantinos Poulas, PhD; Philippe Presles, MD; Public Health England PHE;  Carl Phillips; Lars M. Ramström, PhD; Vaughan Rees, PhD; Deborah Robson, London; Ailsa Rutter, fresh-balance.co.uk; Rose Jed E; Sally Satel, MD; Steven A. Schroeder, MD; John R. Seffrin , PhD; Lion Shahab, PhD, London; Harry Shapiro, MD; Rajesh N. Sharan, PhD.; Michael Siegel, MD; Gerry Stimson,PhD; Martin Storck, MD (surgeon); Heino Stöver, PhD (social science); Roberto A Sussman, PhD; David Sweanor, JD; Umberto Tirelli MD ; UK’s Medicines and Healthcare products Regulatory Agency MHRA; Praneet Valodia, PhD; Natalie Walker, PhD; Kenneth Warner, PhD; Bernd Werse, PhD (sociology); Robert West, PhD; Willette PN; Alex Wodak; Naohito Yamaguchi, MD; Ben Youdan.

Some more partners and accomplices of the nicotine industry may also be found here and in a  letter writing campaign aiming to disturb the COP-9 of WHO-FCTC in 2021, at 2023 conferences in Washington and Seoul , at UKVIA awards, in The Times and in blogs written by Philippe Poirson, Nancy Loucas, etc.. Remarkable is the fast and worldwide distribution of such campaigns by PR agencies. They also distribute biased studies, which serve interests of the tobacco industry, quickly and before peer review. So bought authors get much more attention than they deserve from a scientific point of view. Do not trust NGOs with ties to the tobacco industry! Do not believe in reports of Cochrane Tobacco Advisory Group. Do not rely on "perspectives", which are not based on data. Distrust platforms hiding their sponsors like "www.clearingtheair.eu" or "consumer choice center". Some authors believe that shares owned by their wifes or payment of travel costs do not need to be declared as conflict of interest. If you suspect tobacco industry funding not listed yet, write to https://tobaccotactics.org/.